Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-09-03), Golden Throat Holdings Group Co's Beta is -0.0151.
Golden Throat Holdings Group Co (HKSE:06896) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Golden Throat Holdings Group Co Beta Related Terms
Golden Throat Holdings Group Co Beta Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Golden Throat Holdings Group Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Golden Throat Holdings Group Co Beta vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Golden Throat Holdings Group Co's Beta distribution charts can be found below:
* The bar in red indicates where Golden Throat Holdings Group Co's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Golden Throat Holdings Group Co (HKSE:06896) has a Beta of -0.0151 as of Sep. 03, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Golden Throat Holdings Group Co and its competitors.
Is Golden Throat Holdings Group Co's Beta too high?
Golden Throat Holdings Group Co's current Beta is -0.0151. Overall, Golden Throat Holdings Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Golden Throat Holdings Group Co's Beta compare to ZTS?
Golden Throat Holdings Group Co's Beta of -0.0151 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Golden Throat Holdings Group Co and its competitors. Golden Throat Holdings Group Co's current Beta is -0.0151. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Throat Holdings Group Co stock overvalued right now?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co (HKSE:06896) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$2.98, compared to a current price of HK$2.27 — trading 24% below its estimated fair value. The current Beta is -0.0151. Golden Throat Holdings Group Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Golden Throat Holdings Group Co (HKSE:06896), the current Beta is -0.0151 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Golden Throat Holdings Group Co (HKSE:06896) Overvalued in 2026?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co stock appears to be undervalued.
The current stock price of HK$2.27 is trading 24% below its estimated GF Value™ of HK$2.98.
GuruFocus considers Golden Throat Holdings Group Co to be Modestly Undervalued.
Key valuation signals for HKSE:06896:
Beta: -0.0151
GF Value™: HK$2.98 vs. price of HK$2.27 (24% below fair value)
No single metric tells the full story. See the HKSE:06896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. The compqny manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.
83GF Score
Get the complete analysis for HKSE:06896
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06896 has been successfully added to your 
